Molecular pathology of eyes with von Hippel-Lindau (VHL) Disease: a review. - Wikidata - wikimedia - TriplyDB

Molecular pathology of eyes with von Hippel-Lindau (VHL) Disease: a review.

Molecular pathology of eyes with von Hippel-Lindau (VHL) Disease: a review.

http://www.wikidata.org/entity/Q35980944

about

T-cell lymphoma with von Hippel-Lindau disease: a rare case report and review of literature Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease.Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease Long-term use of intravitreal bevacizumab (avastin) for the treatment of von hippel-lindau associated retinal hemangioblastomas The erythropoietin/erythropoietin receptor signaling pathway promotes growth and invasion abilities in human renal carcinoma cells.Pathology characteristics of ocular von Hippel-Lindau disease with neovascularization of the iris and cornea: a case report.Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.Retinal vascular proliferation as an ocular manifestation of von Hippel-Lindau disease.Clinical and molecular characteristics of East Asian patients with von Hippel-Lindau syndrome.Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma.Congenital vascular malformations of the retina and choroid.Von hippel-lindau disease: a genetic and clinical review.Use of intravitreal bevacizumab in a patient with a Von Hippel-Lindau-associated retinal haemangioblastoma of the optic nerve head: a case report Intravitreal ranibizumab, photodynamic therapy, and vitreous surgery for the treatment of juxtapapillary retinal capillary hemangioma.

P2860

Q26801940-AA3B3525-7C1E-4D82-81B9-FDE655FFAF20 Q30439589-F78FBDC7-88F6-4935-AEA9-D2B46EC72FA4 Q32174211-4BE9976F-03EA-4C68-BC4C-9A82FFFF49D0 Q33811756-7DCD7E01-B52C-4931-AE71-3E6AE8FA4D1B Q34428148-5D8D82B0-92C2-4479-8574-513DA5C34A12 Q35317845-892C3528-C355-4241-87D3-1567515F760D Q35459525-D6E785AF-5765-47FE-84F3-7450DC7D1CDB Q36744308-5AEA60D3-DA8F-4605-85D7-532A6DC1512D Q37178260-7F5F94F4-E020-4520-B556-E0401AC61F25 Q37231081-95513478-C190-4838-B713-D4CF5D8FBFC4 Q37658302-CB85998C-37E9-4FB9-8C05-1C9841EDAC26 Q38153733-85AF037B-AA5C-41B0-AFEC-8BAA07269B30 Q39245217-679F5C20-01A9-464F-9A30-319F0B69263D Q42710391-FD42CE54-8EA6-4149-9493-C2FD66F8531D

P2860

Molecular pathology of eyes with von Hippel-Lindau (VHL) Disease: a review.

http://www.wikidata.org/entity/Q35980944

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Molecular pathology of eyes with von Hippel-Lindau (VHL) Disease: a review.

@ast

Molecular pathology of eyes with von Hippel-Lindau (VHL) Disease: a review.

@en

type

label

Molecular pathology of eyes with von Hippel-Lindau (VHL) Disease: a review.

@ast

Molecular pathology of eyes with von Hippel-Lindau (VHL) Disease: a review.

@en

prefLabel

Molecular pathology of eyes with von Hippel-Lindau (VHL) Disease: a review.

@ast

Molecular pathology of eyes with von Hippel-Lindau (VHL) Disease: a review.

@en

P1433

Q35980944-966E0DCC-7731-4F1F-A9D0-406B8B0ED0E6

P1476

Q35980944-5C0A1929-B345-48CB-8F62-069B25ECC5C8

P2093

Q35980944-C5F438A9-9DF6-4B8F-BDDE-C89889C28857

P2860

Q35980944-0835D78B-6E52-4CDD-B411-136296A306A5

Q35980944-15587A21-85BB-48B8-8A16-1EC5714042B3

Q35980944-1D927ADF-8C3A-4745-BC73-81F826909AAB

Q35980944-1F121E77-D013-4078-B050-27960E9D6857

Q35980944-209B872B-905B-46A5-89FE-9B4E9FC59C35

Q35980944-281681CE-F64B-4839-A58B-926A97F3932C

Q35980944-2AAAEDC5-9EAB-4FEA-AF28-7DB5983DADC0

Q35980944-2D6F92ED-1682-479B-8FE9-2AEF6BE34C87

Q35980944-319981C6-AE14-4C61-A572-4CD0E1387C80

Q35980944-323FD22D-D809-4EE2-92EB-B15C4DE42C6F

P304

Q35980944-8DC44E9D-9617-4E38-AADB-DE3642EDDC07

P31

Q35980944-2A78235B-C962-4191-97EF-04C55CF2092C

P356

Q35980944-B7E1D5FC-2BE2-4DC1-A991-ADEE63D5E5A5

P433

Q35980944-8EEF7064-62A2-4DAB-912F-3A4F1044BB74

P478

Q35980944-E48FB1C9-E431-4063-B02A-E5CAE5429D9E

P50

Q35980944-0DD28647-72A4-4C0A-94B5-049687922B7A

Q35980944-AF8D83CE-5A33-470E-8224-F9934B929B0B

P577

Q35980944-FEED4614-99A0-4818-B3D0-C4FF58D301C5

P5875

Q35980944-D8464438-4B36-49A5-8874-B033B54D5A33

P698

Q35980944-E6CE668B-6D04-41E6-8EF6-F139D4245F5C

P932

Q35980944-2DA66736-FC90-4300-968F-86ECD2A4595B

P356

01.IAE.0000244659.62202.EE

P1433

P1476

Molecular pathology of eyes with von Hippel-Lindau (VHL) Disease: a review.

@en

P2093

Atif Ben Daniel Collins

http://www.w3.org/2001/XMLSchema#string

P2860

VHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1alpha.

Mutation and cancer: statistical study of retinoblastoma

von Hippel-Lindau disease

Molecular basis of the VHL hereditary cancer syndrome

Structure, function, and activation of the erythropoietin receptor

Thrombin induces expression of FGF-2 via activation of PI3K-Akt-Fra-1 signaling axis leading to DNA synthesis and motility in vascular smooth muscle cells

Identification of the von Hippel-Lindau disease tumor suppressor gene

von Hippel-Lindau disease.

Juxtapapillary capillary hemangiomas. Clinical features and visual acuity outcomes.

Rapid and durable recovery of visual function in a patient with von hippel-lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416.

P304

1-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.IAE.0000244659.62202.EE

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6582566

http://www.w3.org/2001/XMLSchema#string

P698

17218907

http://www.w3.org/2001/XMLSchema#string

P932

1971131

http://www.w3.org/2001/XMLSchema#string